Small dense LDL oxidation in hypertensives and diabetics and prediction of Metabolic Syndrome

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 1, 2008, Pages 21-27

  Nishtha, J ^a   Naseem, I ^a   Ahmad, J ^b  

^a Department of Zoology   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Metabolic Syndrome; Oxidation; Paraoxonase; Small dense LDL

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SCREENING; VOLUNTEER; WAIST CIRCUMFERENCE;

EID: 38849093119     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.11.004     Document Type: Article

References (41)

1. Kylin E. Studien ueber das hypertonie-hyperglykamie-hyperurikamiesyndrom. Zentralblatt Innere Med 44 (1923) 105-127
2. Avogaro P., and Crepaldi G. Essential hyperlipaemia, obesity and diabetes. Diabetologia 1 (1965) 137-145
3. Anwar A.J., Barnett A.H., and Kumar S. The metabolic syndrome and vascular disease. In: Johnstone M.T., and Veves A. (Eds). Diabetes and cardiovascular diseases (2001), Humana Press, Totowa, NJ 3-22
4. Reaven G.M. Banting lecture, role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
5. Ferrannini E., Haffner S.M., Mitchell B.D., and Srern M.P. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
6. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation, Part 1 (1999), World Health Organisation, Geneva
7. National Institute of Health. Detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of national cholesterol education program expert pane. Bethesda, MD: National Institutes of Health; 2001.
8. Garin M.C.B., Kalix B., Morabia A., and James R.W. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 2264-2269
9. Bracht C., Locher R., Suter P., and Vetter W. LDL-Oxidation bei essentieller. Hypertonie Kardiovaskuldre Medizin 1 (1997) 54-58
10. Grassi G., Dell'Oro R., and Quarti-Trevano F. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48 (2005) 1359-1365
11. Regnstrom J., Nilsson J., Tornvall P., Landou C., and Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1183-1186
12. La Du B. In: Kalow W. (Ed). Pharmacogenetics of drug metabolism (1992), P.P. Inc., New York p. 51-91
13. Furlong C.E., Li W.F., Costa L.G., Richter R.J., Shih D.M., and Lusis A.J. Genetically determined susceptibility to organophosphorous insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism. Neurotoxicology 19 (1998) 645-650
14. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 (1998) 1581-1590
15. Trinder P. Ann Clin Biochem 6 (1969) 24
16. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Hirano T., Ito Y., Saegura H., and Yoshino G. A novel and simple method for quantification of small dense low-density lipoprotein. J Lipid Res 44 (2003) 2193-2201
18. Hirano T., Ito Y., Koba S., Toyoda M., Ikejiri A., Saegusa H., et al. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 24 (2004) 558-563
19. Esterbauer H., Striegl G., Puhl H., and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6 (1989) 67-75
20. Emma Ashton L., Fabien S.D., and Madeleine J.B. Effect of meat replacement by Tofu on CHD risk factors including copper induced LDL oxidation. J Am Coll Nutr 19 (2000) 761-767
21. De Geest B., Stengel D., Landeloos M., Lox M., Le Gat L., Collen D., et al. Effect of overexpression of human apo A-1 in C57BL/6 and C57BL/6 apo-E deficient mice on 2 lipoprotein associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo [1A-] gene transfer and human apo A-1 transgenics. Arteroiscl Thromb Vasc Biol 20 (2000) E68-E75
22. Navab M., Hama-Levy S., Van Lenten B.J., Fonarow G.C., Cardinez C.J., Castellani L.W., et al. Mildly oxidised LDL induces an increased apolipoprotein paraoxonase ratio. J Clin Invest 99 (1997) 2005-2019
23. Sakai T., Matsuura B., and Onji M. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus. Intern Med 37 37 (1998) 581-584
24. National Cholesterol Education Program (NCEP). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults [adult treatment panel III]: final report. Circulation 106 (2002) 3143-3421
25. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lentant C. National Heart, Lung and Blood Institute, American Heart Association. Definition of Metabolic Syndrome: report of the National Heart. Lung and Blood Institute American Heart Association Conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24 (2004) 13-18
26. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. National High Blood Pressure Education Program Coordinating Committee: seventh report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
27. Allemann Y., and Weidmann P. Cardiovascular, metabolic and hormonal disregulation in normotensive offspring of essential hypertensive parents. J Hypertens 13 (1995) 163-173
28. Pierdomenico S.D., Constantini F., Bucci A., De Cesare D., Cuccurullo F., and Mezzetti A. Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. Hypertension 31 (1998) 621-626
29. Witzum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
30. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: modifications of low-density lipoproteins that increases its atherogenicity. N Engl J Med 320 (1989) 1196-1197
31. Witztum J.L., and Steinberg D. Role of oxidised low-density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
32. Brockes C., Buchli C., Locher R., Koch J., and Vetter W. Vitamin E prevents extensive lipid peroxidation in patients with hypertension. Br J Biomed Sci 60 (2003) 5-8
33. Devraj S., and Jialal I. The effects of alpha-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 9 (1998) 11-15
34. Shimano H., Yamada N., and Ishibashi S. Oxidation-labile subfraction of human plasma low-density lipoprotein isolated by ion-exchange chromatography. J Lipid Res 32 (1991) 763-773
35. Vasankari T., Ahotuba M., and Toikka J. Oxidised LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men with lower levels of oxidised LDL with statin therapy. Atherosclerosis 155 (2001) 403-412
36. Vega G.L., and Grundy S.M. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 7 (1996) 209-216
37. Karabina S.A.P., Lehner A.N., Frank E., Parthasarathy S., and Santanam N. Oxidative inactivation of paraoxonase: implications in diabetes mellitus and atherosclerosis. BBA 1725 (2005) 213-221
38. Chuyen N.V. Maillard reaction and food processing. Application aspects. Adv Exp Med Biol 434 (1998) 213-235
39. England M.D., Cavarocchi N.C., O'Brien J.F., Solis E., Pluth J.R., Orszulak T.A., et al. Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass. Circulation 74 (1986) III134-III137
40. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J., and Durrington P.N. Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15 (1995) 1812-1818
41. Jurek A., Turyna B., Kubit P., and Klein A. LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure. Clin. Biochem. 39 (2006) 19-27